Headquarters: Ann Arbor, Michigan, United States
Technology: Neurological Disorders
Industry: Gene Therapy
Total Funding: $106M
Estimated Revenue: Less than $1M
Investors Number: 12
Founded Date: 2009
Last Funding Type: Venture - Series Unknown
Funding Status: M&A